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IMMUNOLOGY

Cosmc deficiency causes spontaneous autoimmunity
by breaking B cell tolerance
Junwei Zeng1*, Rajindra P. Aryal1, Kathrin Stavenhagen1, Chi Luo2†, Renyan Liu3,
Xiaohui Wang4‡, Jiaxuan Chen1, Hao Li5, Yasuyuki Matsumoto1, Yingchun Wang6,
Jianmei Wang6, Tongzhong Ju6§, Richard D. Cummings1*
Factors regulating the induction and development of B cell–mediated autoimmunity are not well understood.
Here, we report that targeted deletion in murine B cells of X-linked Cosmc, encoding the chaperone required for
expression of core 1 O-glycans, causes the spontaneous development of autoimmune pathologies due to a breakdown
of B cell tolerance. BC-CosmcKO mice display multiple phenotypic abnormalities, including severe weight loss,
ocular manifestations, lymphadenopathy, and increased female-associated mortality. Disruption of B cell tolerance
in BC-CosmcKO mice is manifested as elevated self-reactive IgM and IgG autoantibodies. Cosmc-deficient B cells
exhibit enhanced basal activation and responsiveness to stimuli. There is also an elevated frequency of spontaneous
germinal center B cells in BC-CosmcKO mice. Mechanistically, loss of Cosmc confers enhanced B cell receptor (BCR)
signaling through diminished BCR internalization. The results demonstrate that Cosmc, through control of core 1
O-glycans, is a previously unidentified immune checkpoint gene in maintaining B cell tolerance.
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Glycosylation is an important posttranslational modification
(PTM) that has been implicated in multiple AIDs (11–17).
Abnormally glycosylated immunoglobulins have been found in
immunoglobulin A (IgA) nephropathy (IgAN), systemic lupus
erythematosus, and other AIDs. Interactions between sialic acid–
binding immunoglobulin type lectins (Siglecs) and sialic acids are
involved in autoimmunity by regulating BCR and Toll-like receptor
(TLR) signaling. In response to both developmental and environmental cues, dynamic glycosylation has been well documented on
immune cells and molecules. In the context of AID pathogenesis,
such dynamic glycosylation changes might play roles in mediating
the initiation and progression of AID but are largely unexplored.
A major PTM of surface proteins in B cells is the addition
of O-glycans through formation of core 1 O-glycans (R-Gal13GalNAc1-Ser/Thr/Tyr). The generation of O-glycans, which are
abundantly present on leukocytes (18–22), requires expression of
both Cosmc (C1GalT1C1), a molecular chaperone in the endoplasmic
reticulum, and its only client, the Core 1 3galactosyl-tranferase
(C1GalT1), also known as T-synthase. We recently demonstrated
that deletion of Cosmc in murine B cells, which results in expression of
the Tn antigen (GalNAc1-Ser/Thr/Tyr), greatly reduces their migration to lymph nodes (23). We also observed that the B cell-specific
Cosmc-knockout (BC-CosmcKO) mice displayed splenomegaly and
hypergammaglobulinemia, indicating the potential development
of AID. Cosmc is an especially interesting candidate gene, as it has
been recently implicated in several autoimmune and inflammation-
associated diseases, including inflammatory bowel diseases (24),
IgAN (25), Tn syndrome (26), and Alzheimer’s disease (27).
Here, we report that Cosmc deficiency in B cells causes a breakdown of B cell tolerance. BC-CosmcKO mice spontaneously display
multiple AID-like pathological phenotypes, in an age- and gender-
associated manner. Cosmc deficiency prolongs the retention of the
BCR on cell surface and promotes stronger BCR signaling, which
likely led to B cells’ hyperresponsiveness to stimuli. These results
demonstrate that the presence of Cosmc, required for normal O-glycans
on B cell glycoproteins, controls B cell tolerance by maintaining
BCR signaling through regulating surface BCR internalization.
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B cells play pivotal roles in mediating the pathogenesis of autoimmune diseases (AIDs), which affect ~7 to 9% of the world population (1–3). A hallmark of autoimmunity is the breach of B cell
tolerance, where B cells are unable to distinguish self-antigens from
non–self-antigens and eventually lead to the emergence of pathogenic autoantibodies. Nonetheless, the molecular factors underneath
the initial development and expansion of pathogenic autoreactive
B cells remain incompletely understood.
The B cell receptor (BCR) is the master regulator in controlling
B cell development, differentiation, survival, and tolerance (1, 4, 5).
It is essential for B cells to receive, process, and integrate both the
antigenic signals delivered via BCR and environmental cues relayed
via other receptors as they give rise to opposing outcomes. The
B cells are either appropriately activated and generate high-affinity
antibodies against foreign antigens, or they become tolerogenic
upon interaction with self-antigens. Multiple physiological processes to keep autoreactive B cells in check have been found (6–9).
Nonetheless, in the periphery, a notable percentage of B cells in
healthy host exhibit autoreactivities (7, 10), suggesting the existence
of undefined mechanisms underlying the fine-tuned regulation of
B cell activities.
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RESULTS

AID-like pathological features in BC-CosmcKO mice
A range of obvious phenotypic abnormalities (Fig. 1) spontaneously
developed in aged (11 to 20 months) BC-CosmcKO mice, although
they appeared healthy at younger ages (8 weeks). Significant weight
loss occurred in adult (3 to 7 months) female and both gender
groups in aged BC-CosmcKO mice (Fig. 1A); however, the severity
of the weight loss was greater in female mutant mice. Moreover, a
substantial portion of mutant mice displayed ocular abnormalities
in a syndromic fashion, ranging in severity from cataracts, keratitis,
and watery eyes to a complete eye closure or loss of the eyeball in
some mutant mice (Fig. 1, B and C, and fig. S1, A to C). In addition,
a higher incidence of dermatitis occurred in aged female BC-CosmcKO
mice (Fig. 1, D and H).
We observed enlarged spleen in young (2 to 4 months) (23) but
not in aged (11 to 20 months) male BC-CosmcKO mice (fig. S1D,
left). By contrast, female mice had significantly larger spleens in
both young (2 to 4 months) and older aged groups (11 to 20 months)
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(Fig. 1E and fig. S1D, right). Aged BC-CosmcKO female mice also
exhibited lymphadenopathy and lymphadenitis (Fig. 1, F and H).
Notably, ~73% of the lymph nodes exhibited severe inflammation
(Fig. 1F, bottom). Tissue pathological features were evident in the
liver of aged female mutant mice, characterized by fibrosis, ductular
reaction, and necrosis and inflammation (Fig. 1, G, right, and H).
However, the liver of aged male mutant mice was mildly affected,
and the animals exhibited resistance to age-associated hepatic
steatosis (fig. S1E).
By 18 months, 14% (6 of 44) of female mutant mice became
moribund, whereas only 2% (1 of 41) of wild type (WT) expired
(Fig. 1I). Together, BC-CosmcKO mice exhibited various tissue
pathologies that are typically associated with AIDs, with a strong
female bias.
Loss of B cell tolerance in BC-CosmcKO mice
We observed an increased level of total IgM and IgG and a reduced
level of IgA in the sera of young (2 months) and aged (11 to 20 months)
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Fig. 1. AID-like pathological features in BC-CosmcKO mice. Obvious phenotypic abnormalities of aged [11 to 20 months (mo.)] female and male mice from both
BC-CosmcKO and WT littermate controls were documented (A to F). Body weight of both adult (3 to 7 months) and aged mice from both genders is shown (A): adult
female: WT 26.75 ± 3.37, BC-CosmcKO 24.58 ± 1.26; adult male: WT 31.25 ± 2.15, BC-CosmcKO 30.57 ± 2.09; aged female: WT 32.26 ± 5.06, BC-CosmcKO 29.14 ± 3.27; aged
male: WT 44.48 ± 6.92, BC-CosmcKO 39.61 ± 7.68. Each symbol (black square, WT; open circle, BC-CosmcKO) represents an individual mouse body weight, graphed as
means ± 1 SD. Ocular manifestations (B and C) and dermatitis (D). Spleens (E) and cervical lymph nodes (F) of aged female mice. Representative images from both WT and
BC-CosmcKO mice are shown in (B) to (F); n = 12 for WT and n = 26 for BC-CosmcKO (E). (G) Liver damage in aged female Cosmc mutant mice. Liver sections were stained
with hematoxylin and eosin (H&E). Yellow arrows indicate necrosis and inflammation. Black arrows indicate ductular reaction. Red arrows indicate fibrosis. (H) Summary of
examined animals in (D), (F), and (G). Liver H&E images were acquired at ×20 magnification. Scale bars, 100 m. (I) Bar graphs represent mortality summary of both BC-CosmcKO
and WT littermate controls. Each symbol (black square, WT; open circle, BC-CosmcKO) represents an individual mouse, graphed as means ± 1 SEM. ns, not significant.
Unpaired two-tailed Student’s t tests were performed to determine statistical significance, *P < 0.05, **P < 0.01, and ***P < 0.001. Photo credit: Junwei Zeng, Beth Israel
Deaconess Medical Center.
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male BC-CosmcKO mice (Fig. 2A) (23), and an altered immunoglobulin profile was also observed in young female BC-CosmcKO
mice (Fig. 2B). By contrast, compared to WT, aged (11 to 20 months)
female BC-CosmcKO mice exhibited increased serum IgM levels.
However, total IgG or IgA levels were unaltered (Fig. 2A). To examine
whether the B cell tolerance was impaired in the mutant mice, we
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measured the titers of immunoglobulins that recognize double-
stranded and single-stranded DNA (dsDNA and ssDNA). We
observed increased titers of anti-dsDNA and anti-ssDNA IgG and
IgM in female BC-CosmcKO mice of both young (Fig. 2C, right) and
aged groups (Fig. 2D, right). Such increased autoreactive antibody
levels were only observed in young male (Fig. 2C, left) but not in old

Fig. 2. Loss of Cosmc breaks B cell tolerance. Total immunoglobulins (A and B) and anti-dsDNA and anti-ssDNA antibodies (C and D) in sera from both BC-CosmcKO and
WT littermate controls measured by ELISA. NC, negative control (media only); PC, positive control (MRL/lpr serum). All groups include 16 WT and 16 BC-CosmcKO mice in
(A) and (B) and 10 WT and 11 BC-CosmcKO mice in (C) and (D), except for 14 WT and 15 BC-CosmcKO mice in the young male group. KO, BC-CosmcKO. Each symbol (black
square, WT; open circle, BC-CosmcKO) represents an individual mouse, graphed as means ± 1 SEM. Unpaired two-tailed Student’s t tests were performed to determine
statistical significance, *P < 0.05, **P < 0.01, and ***P < 0.001. (E) Autoreactive antibodies of BC-CosmcKO mice. Serum samples (1:90 dilution) from BC-CosmcKO and WT
littermate controls assayed by HEp-2 cell staining. Images were acquired at ×63 magnification. Representative images from young male WT and BC-CosmcKO mice are
shown in (E). Scale bars, 20 m. (F) Summary of assayed samples from 2- to 4-month-old BC-CosmcKO mice of both genders. (G) Immunoglobulin deposition in kidneys of male
BC-CosmcKO mice. Kidney images were acquired at ×20 magnification. Representative images from both WT (n = 4) and BC-CosmcKO male mice (n = 4) are shown. Scale
bars, 50 m. (H) BN-APAGE analysis of mouse serum. IgM (top) and IgG (bottom) of four young female and three male mice of each genotype are shown. Serum or
tissues were collected from aged (11 to 20 months old) and young (2 to 4 months old) mice of indicated gender.
Zeng et al., Sci. Adv. 2020; 7 : eabg9118
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classic, lectin, and alternative pathways and has been implicated in
autoimmunity. Western blot analyses showed an increased circulating
level of C3 in the sera of several aged female BC-CosmcKO mice,
concomitantly with reduced C3 breakdown products (fig. S3, C and D).
The irregular presence of C3 and its split products indicates that the
complement cascade might play a role in the pathogenesis of the
observed disease in aged female BC-CosmcKO mice. Together,
these results indicate that deletion of Cosmc in B cells disrupts B cell
tolerance, which is associated with altered immune effector factors.
Hyperresponsiveness of Cosmc-deficient B cells
Disrupted B cell tolerance is often associated with irregular B cell
development and B cell hyperresponsiveness (2, 37). We have
observed altered percentage and numbers of marginal zone (MZB)
and follicular (FO) B cell in the spleen of BC-CosmcKO mice (23).
To functionally characterize these B cell subsets, we used flow
cytometry to measure their uptake of a model antigen trinitrophenol
(TNP)–Ficoll, which is a T-independent antigen that is quickly
trapped by MZB and marginal zone precursor (MZP) after intravenous injection (38). We observed comparable binding of TNP-Ficoll
in both WT and BC-CosmcKO MZB cells, functionally confirming
that the increased B cell subset in BC-CosmcKO mice is MZB cells
(23). By contrast, Cosmc-deficient FO B cells demonstrated significantly higher ability to bind to TNP-Ficoll (Fig. 3A). Furthermore,
total Cosmc-deficient B cells (Fig. 3B) and subsets (fig. S4A) also
showed higher expression of CD9 and CD1d, markers for MZB
cells. Together, these data indicated that loss of Cosmc affects the
differentiation of splenic B cells toward the MZB cell pathway.
We have observed enhanced basal immunoglobulin amounts in
BC-CosmcKO mice (Fig. 2A and fig. S2A) (23), which may result
from a generalized hyperactivation of B cells. Flow cytometry analysis
indicated that Cosmc-deficient B cells display enhanced basal activation, as measured by the surface expression of activation markers,
including CD86, CD80, and major histocompatibility complex class
II (MHC II) (Fig. 3C and fig. S4, B and C). Furthermore, we explored
whether Cosmc mutation affects B cell responsiveness to anti-IgM
in the absence or presence of anti-CD40 and oligodeoxynucleotide
1826 (ODN 1826) stimulation in vitro. By measuring CellTrace
Violet dilution, we observed that Cosmc-deficient B cells behaved
similarly to WT B cells in terms of cell division upon anti-IgM stimulation. The addition of anti-CD40 stimulation, however, led to
reduced division in Cosmc-deficient B cells (Fig. 3, D and E), compared to WT. Cosmc-deficient B cells showed impaired viability
compared to WT cells upon anti-IgM activation, indicating elevated
sensitivity to BCR cross-linking; the difference in viability was
reduced in the presence of anti-CD40 (Fig. 3, D and F). By contrast,
ODN 1826 alone induced significantly more division and expansion
of Cosmc-deficient B cell (Fig. 3, D to F). These results indicate that
Cosmc-deficient B cells are hyperresponsive to BCR stimulation (in
vivo and in vitro), as well as other signals, such as a TLR signal. This
altered responsiveness, together with the perturbed B cell differentiation, is reminiscent of those found in autoreactive B cells seen in
AID patient and animal models (37, 39, 40).
Cosmc deficiency leads to increased spontaneous
germinal center B cells
Germinal center B (GCB) cells play essential roles in maintaining
B cell tolerance (41, 42). The first surface marker historically to
identify GCB cells was high binding of peanut agglutinin (PNA)
4 of 13
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male BC-CosmcKO mice (Fig. 2D, left). These results demonstrate
that BC-CosmcKO mice produce autoreactive antibodies, indicating
a breach in B cell self-tolerance.
As a more comprehensive assessment of self-reactivity, we
collected sera from both WT and BC-CosmcKO mice (2 months) to
test the autoantigen specificity by an indirect immunofluorescence
assay using HEp-2 cells, a method commonly used to identify autoreactive antibodies. While sera from WT mice had minimal reactivity,
sera from all BC-CosmcKO mice (75 of 75) demonstrated autoreactivities and yielded multiple staining patterns (Fig. 2E and fig.
S2A, right). Moreover, consistent with the enhanced autoreactive
IgM titers in mutant mice shown by enzyme-linked immunosorbent
assay (ELISA), the staining specificity was not only restricted to IgG
antibodies but was also observed with IgM, suggesting an early
break of B cell tolerance in Cosmc-deficient B cells (Fig. 2E and
fig. S2A). We observed that sera from 69% of the BC-CosmcKO animals
exhibited self-reactive IgG with a nuclear/cytoplasmic staining
pattern, whereas the remaining 31% exclusively stained nuclei. By
contrast, for IgM, 85% of the BC-CosmcKO mice sera displayed
IgM nuclear/cytoplasmic staining, 9% stained the cytoplasm, and
5% displayed no staining (Fig. 2F). There was a higher percentage of
autoreactive IgG staining nuclei in sera from female BC-CosmcKO
mice (47% versus 25% in male) (fig. S2B). Notably, staining by IgM
did not necessarily reflect the same staining pattern as the IgG of the
same BC-CosmcKO mouse. The wide spectrum of self-reactive
staining patterns of immunoglobulins from BC-CosmcKO mice
indicates that they have a breakdown of B cell tolerance. Immunofluorescence staining analysis on kidney sections of the mutant
mice also showed notable deposits of IgG and IgM antibodies when
compared to WT (Fig. 2G and fig. S2C), suggesting potential immune
complex deposition in tissues. Nonetheless, aged BC-CosmcKO mice
showed similar range of urinary protein and other substances to
those in the WT (fig. S2, D and E), indicating normal renal function. In addition, histopathological evaluation shows the absence of
severe kidney structural changes in aged males, with slightly higher
glomerular alteration scores in aged female BC-CosmcKO mice
(fig. S2, F and G).
The uncontrolled autoantibodies may contribute to disease
progression by multiple effector mechanisms (28, 29). The high titers
of autoantibodies in sera of BC-CosmcKO mice prompted us to
examine the presence of circulating immune complexes, as immune
complexes are formed during the progressive course of many human
diseases, including AIDs (30, 31). We used the blue native–agarose
polyacrylamide gel electrophoresis (BN-APAGE) system, which
resolves native protein complexes up to 6 MDa or greater (32). A
range of immune complexes of IgG and IgM, with varying molecular
weights, was observed in the sera of the young (2 months) mutant
female and male mice (Fig. 2H). However, aged mice (11 to
20 months) did not show consistent differences in the presence of
such macromolecular immune complexes (fig. S2H). It is conceivable
that over time, immune complexes may progressively precipitate in
tissues or lessen in blood. Inflammatory cytokines have been implicated in the development of AIDs (33, 34). In the present study, we
observed a mild but significant increase of tumor necrosis factor–
(TNF) but not interferon- (IFN) in the sera of aged female
Cosmc mutant mice, indicating a state of low-grade, chronic inflammation in these mice (fig. S3, A and B). The complement
system is another downstream effector arm of autoantibody-mediated
injury (35, 36). Complement C3 is the convergent point of the
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experiments. Each symbol (black square, WT; open circle, BC-CosmcKO) represents an individual mouse, graphed as means ± 1 SEM. Young (2 to 4 months old) male mice
were used in (A) to (F). Unpaired two-tailed Student’s t tests were performed to determine statistical significance, *P < 0.05, **P < 0.01, and ***P < 0.001.
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to WT GCB cells compared to Cosmc-deficient GCB cells. We found
a substantially increased percentage of spontaneous GCB cells
in all lymphoid tissues of BC-CosmcKO mice (Fig. 4C). Similar
results with a higher percentage of GCB cell population were also
found in BC-CosmcKO mice, using another set of GCB cell marker
CD38lo and Fas+ (fig. S5C). These data indicate that Cosmc plays a
negative regulatory role in the development of GCB cells.
Cosmc-deficient B cells retained their ability to generate antibodies
specific to type I and type II T-independent immunogens 4-hydroxy-
3-nitrophenylacetyl–conjugated lipopolysaccharide (NP-LPS) and
NP-Ficoll, respectively, and T-dependent immunogen NP-conjugated
keyhole limpet hemocyanin (NP-KLH). Significant difference in
NP-specific IgM level at an early stage was observed when animals
were immunized with NP-Ficoll, a chemical agent that activates
MZB cells (fig. S6, A and B). By contrast, after challenge with NP-KLH,
comparable NP-specific IgG levels were observed in BC-CosmcKO
mice at early stages (Fig. 4D). Later on, at day 28, the mutant mice
expressed a reduced NP-specific IgG1 titer and a negligible IgG3
response to NP-KLH (Fig. 4E). These results mirror our previously
observed difference in basal serum IgG3 level, which was extremely
low in BC-CosmcKO mice (23). These data indicate that Cosmc
plays an essential role in mediating isotype switching to IgG3.
Furthermore, we observed a notable reduction in the level of
high-affinity NP-specific IgG in BC-CosmcKO mice at day 28 after
NP-KLH immunization (Fig. 4F).
Impaired BCR internalization of Cosmc-deficient B cells
Consistent with our previous finding (23), we observed that the
expression level of IgM was elevated on naïve Cosmc-deficient B cells
(Fig. 5A). Using quantitative polymerase chain reaction (PCR), we
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(43, 44), a plant lectin that specifically binds to the core 1 O-glycan,
Gal1-3GalNAc1-Ser/Thr-R. The rapid increase of PNA binding
on GCB cells suggests that once B cells differentiate and take on
GCB cell features, abundant core 1 O-glycans are concomitantly
expressed on the cell surface. Nonetheless, the physiological relevance
of this sudden increase of core 1 O-glycans on GCB cells remains
completely unknown. Notably, the galactose in core 1 O-glycans is
added by T-synthase, an enzyme requiring Cosmc for its folding and
consequent activity (20–22). To gain insights into the significance
of PNA ligands on GCB cells, we characterized glycans on naïve
splenic WT and Cosmc-deficient B cells by using a panel of lectins
that selectively recognize different glycan structures (Fig. 4A and
fig. S5A). As expected, WT B cells bound PNA substantially higher
than Cosmc-deficient B cells with or without neuraminidase treatment, by which removal of sialic acids can expose the core 1 O-glycans.
Consistent with this, we observed that naïve WT B cells are strongly
bound by MAL II, a lectin which recognizes the sialylated core 1
O-glycan; binding was decreased after neuraminidase treatment. By
comparison, Cosmc-deficient B cells exhibited low MAL II binding
under both conditions. We observed that Cosmc-deficient B cells display
higher binding of the lectin Con A, which recognizes -mannosyl
structures on N-glycans, and higher binding of Sambucus nigra
agglutinin (SNA), which binds to Sia2,6 structure on N-glycans;
such glycans might be more accessible on cell surfaces as a result of
loss of extended O-glycans. These results indicate that the glycans
recognized by PNA on B cells are core 1 O-glycans, whose expression is decreased on Cosmc-deficient B cells. When GCB cells
(B220+Fas+GL7+) from mesenteric lymph node (Fig. 4B) or spleen
(fig. S5B) were stained with PNA and binding assessed by mean fluorescence intensity (MFI), there was substantially higher PNA binding
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Fig. 4. Enhanced spontaneous GCB cells in BC-CosmcKO mice. Binding analysis of biotinylated lectins PNA, MAL II, SNA, and Con A, followed by streptavidin–Alexa
Fluor 488, on neuraminidase- or PBS-treated WT and BC-CosmcKO splenic B cells (A). PNA binding of GCB cells (B220+ or CD19+ GL7+ Fas+) and non-GCB cells (B220+ or
CD19+ GL7− Fas−) (B). Right: MFI of lectin binding on indicated B cell population is shown for each WT and BC-CosmcKO mouse in (A) and (B). (C) Representative FACS plots
of GCB cells in BC-CosmcKO mice in indicated tissues. Right: Percentage of GCB cells of total B cells is shown for each WT and BC-CosmcKO mouse. (D and E) NP-specific
immunoglobulin responses to immunization with NP-KLH. (F) Ratio of NP-specific high-affinity IgG to total NP-specific IgG was from two experiments with similar results.
In (D), n = 15 for both WT and BC-CosmcKO mice. In (E) and (F), n = 15 for both WT and n = 14 for BC-CosmcKO mice at day 28. Representative plots from both WT and
BC-CosmcKO mice are shown in (A) to (C). Each symbol (black square, WT; open circle, BC-CosmcKO) represents an individual mouse, graphed as means ± 1 SEM. Young
(2 to 4 months old) male mice were used in (A) to (F). Unpaired two-tailed Student’s t tests were performed to determine statistical significance, **P < 0.01 and ***P < 0.001.

observed a reduced IgM mRNA transcript level in Cosmc-deficient
B cells (Fig. 5B). One possible explanation of such divergence could
be a defect in BCR internalization as a result of Cosmc deficiency.
To investigate the effect of Cosmc deficiency on BCR internalization, we first examined the constitutive endocytosis of IgM. Both
WT and Cosmc-deficient B cells were labeled with biotinylated Fab′
anti-IgM monoclonal antibody, which is unable to activate B cells
but internalized with the BCR (45, 46). The cell surface BCR level
was then measured before and after incubation at 37°C by flow
cytometry. The results indicate that BCR internalization is markedly
impaired in Cosmc-deficient B cell, compared to WT (Fig. 5C).
Next, we evaluated BCR internalization in response to ligand
stimulation by incubating B cells with biotinylated F(Ab′)2 anti-IgM
monoclonal antibody, which activates B cells by cross-linking
surface BCR, in a T cell–independent manner (46, 47). We observed
that Cosmc-deficient B cells needed longer stimulation times to
reach the similar levels of BCR internalization as in WT B cells
(Fig. 5D). However, using the same stimulation time, the degree of
BCR internalization in Cosmc-deficient B cells was consistently
Zeng et al., Sci. Adv. 2020; 7 : eabg9118

6 October 2021

lower than that in WT B cells at all time points examined. Thus,
Cosmc is required for both spontaneous and ligand-induced BCR
internalization.
Upon ligand stimulation, some BCRs remain at the cell surface
and cooperate with other co-receptors to initiate signal transduction, whereas the other BCRs are rapidly internalized (48). Thus, we
reasoned that sustained surface BCR retention on Cosmc-deficient
B cells could be associated with dysregulated BCR signals. To
examine this possibility, we used a phospho-flow assay to analyze
the phosphorylation kinetics of extracellular signal–regulated kinase
1/2 (ERK1/2), spleen tyrosine kinase (SYK), and total cellular proteins
in both WT and Cosmc-null B cells after anti-IgM cross-linking
stimulation. The basal phosphorylation levels of ERK1/2, SYK, and
total cellular proteins were higher in Cosmc-deficient B cells,
compared to WT B cells (Fig. 5E and fig. S6C). After anti-IgM
activation, the up-regulation of phosphorylation levels of the aforementioned molecules continued and prolonged over time. We also
observed enhanced activation kinetics of Erk1/2 in Cosmc-deficient
B cells using phosphorylated protein Western immunoblotting
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Fig. 5. Cosmc deficiency leads to impaired BCR internalization and enhanced BCR signaling. (A) Representative histogram plot of IgM surface expression on B220+
B cells of both WT and BC-CosmcKO mice. Right: MFI of IgM on B cells. Results are representative of three independent experiments with at least three animals in each
group. (B) Transcript level of IgM in purified B cells of both WT and BC-CosmcKO mice. n = 5 for WT and n = 8 for BC-CosmcKO. (C) Spontaneous IgM internalization by WT
and BC-CosmcKO B cells incubated for indicated periods of time as measured by biotinylated Fab′ anti-IgM antibody. (D) Ligand-activated IgM internalization by WT and
BC-CosmcKO B cells incubated for indicated periods of time as measured by biotinylated F(Ab′)2 anti-IgM antibody. Experiments in (C) and (D) were repeated four times
with similar results. Each symbol (black square, WT; open circle, BC-CosmcKO) represents an individual mouse. Graphed as means ± 1 SEM. Young (2 to 4 months old) male
mice were used in (A) to (F). Unpaired two-tailed Student’s t tests were performed to determine statistical significance, **P < 0.01 and ***P < 0.001. (E) Phospho-flow
cytometry analysis of WT and BC-CosmcKO B cells stimulated with anti-IgM antibody for indicated periods of time, assessing the intensity of phosphorylated SYK, ERK1/2,
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immunoblotting of WT and BC-CosmcKO B cells stimulated with anti-IgM antibody (10 g/ml) for indicated periods of time. Experiments were repeated two times
with similar results.

(Fig. 5F). These results indicate that Cosmc deficiency causes
impaired BCR internalization, which may lead to the observed
increased surface IgM BCR levels, and subsequently enhanced BCR
signaling and the resultant hyperresponsiveness of Cosmc-deficient
B cells.
DISCUSSION

By developing a mouse line in which Cosmc was specifically deleted
in B cells, we found that the absence of core 1 O-glycans on B cells
can spontaneously initiate the development of AID. In the mutated
animals, we observed a high production of autoreactive antibodies,
as well as a range of pathological alterations in multiple organs. We
mechanistically show that the absence of core 1 O-glycans on B cells
prolongs the surface retention of BCR that contributes to the enhanced BCR signaling. We also observed that Cosmc-deficient B cells
Zeng et al., Sci. Adv. 2020; 7 : eabg9118
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display generalized hyperresponsiveness with regard to increased
total serum IgM and IgG levels and spontaneous GCB cells. These
findings represent a previously unappreciated critical role of glycosylation in the development of autoimmunity.
Glycosylation regulates multiple aspects of B cell biology,
including B cell development, homing, and immunoglobulin effector
function (11–17, 23, 49). Abnormally sialylated, galactosylated, and
fucosylated N-glycans on glycoproteins such as immunoglobulins
are often associated with multiple AIDs. However, how such aberrant
glycosylation contributes to the pathogenesis of AID remains
unanswered. Our study provides the first evidence that loss of core
1 O-glycans in B cells can trigger the development of AID (Fig. 1).
We demonstrated that such glycosylation on B cells affects BCR signaling through regulating BCR surface retention (Fig. 5, C and D).
Glycosylation on immune cells and molecules is known to be
malleable to environmental exposure and developmental signals.
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(Fig. 4A). We have also reported the presence of abnormal B cell
subpopulations in the bone marrow and periphery of BC-CosmcKO
mice (23). Together, the results indicate a regulatory role of PNA
receptors in B lymphocyte development.
To date, only a handful of surface makers—including PNA, Fas,
CD38, and GL7—have been used to define GCB cells in both humans
and mice (65–68). The latter three markers are directly or indirectly
identified by characterizing the PNA+ GCB cells. Nonetheless, their
roles in the development of GCB cells are rather mild. Our current
studies on genetic deletion of the Cosmc show that the core 1 O-glycan
is the main ligand of PNA on GCB cells (Fig. 4B). Moreover, loss
of core 1 O-glycans on B cells appears to unleash the GCB cell
response, and the percentage of GCB cell rises up to 10 times higher
than that in WT mice (Fig. 4C), suggesting a negative role for core 1
O-glycans in the development of GCB cells. Furthermore, even the
overall NP-specific IgG titers are similar in WT and BC-CosmcKO
mice, which suggests that immunoglobulin class switching was not
affected in B cells’ loss of core 1 O-glycans. However, the titer of
high-affinity (anti-NP2) antibody was lower in BC-CosmcKO mice,
suggesting a regulatory role of core 1 O-glycan in antibody affinity
maturation process.
Our results indicate that BC-CosmcKO mice represent a new
animal model for AIDs based on several lines of evidence. First, a
spectrum of AID clinical features spontaneously arises in BC-CosmcKO
mice, including weight loss, skin lesions, splenomegaly, hypergammaglobulinemia, and lymphadenopathy (23) (Figs. 1 and 2). We
also found other disease manifestations such as ocular abnormalities
and liver pathology, which are frequently found in human AIDs but
not often seen in other animal models. Although the pathogenic
mechanisms underlying these diseases remain to be investigated, it
would be informative to test strategies to treat or alter the progression
of the observed diseases, such as immunosuppression and administration of murine or human intravenous immunoglobulin. Moreover, the differential HEp-2 immunostaining patterns observed in
BC-CosmcKO mice indicated that Cosmc deficiency in B cells resulted in a diverse repertoire of self-reactive Tn+ B cell clones that
have the capacity to readily differentiate and secrete destructive
autoantibodies. Further exploration of factors that induce the differentiation of Tn+ B cells will help to understand the etiology of B
cell–mediated AIDs. The causal relationship between elevated autoantibodies and the pathologies has not yet been established. An
adoptive transfer experiment of serum or purified antibodies from
BC-CosmcKO mice into recipients should be considered next,
although B cells might also contribute to the pathogenesis of AIDs in
an antibody-independent manner. Second, many of the pathological
phenotypes occurred in BC-CosmcKO mice follow a female bias,
mirroring the prevalence of most AIDs in females. Therefore, how
gender-related factors, such as hormones, affect the initiation and
progression of AID could be pursued using this mouse line.
In addition to our finding of compromised BCR signaling in
B cells from BC-CosmcKO mice, the molecular mechanisms by
which O-glycans may regulate B cell activities remain to be studied.
Previous studies show that the retention of BCR on cell surface is
modulated by multiple factors (46, 69, 70). Uncoupling of CD19,
one of the BCR co-receptors, resulted in altered BCR internalization
via limiting its access to lipid rafts. Mutation of Ig (CD79b) also
changed the BCR internalization in a murine model. The retaining
surface BCRs can be inductively phosphorylated and initiate signaling
(48). Notably, many B cell surface molecules are predicted to be
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Our study suggests that such factors may be able to skew immune
cells, such as B cells, toward autoreactive pathway through altering
O-glycosylation modification. In particular, it is important to note
that reversible epigenetic hypermethylation of the promoter for
Cosmc is known to arise in multiple disease conditions, including
AID (50). Altered gene methylation is a known epigenetic mechanism involved in immune cell function in autoimmunity, including
systemic lupus erythematosus (SLE) (51). In addition, the association of pathogen infections and AID pathogenesis has been suggested
by epidemiological studies (52, 53). However, the mechanism underlying such correlation remains elusive. It is noteworthy that pathogens can alter cellular glycosylation, as in sepsis, by introducing
deleterious glycosidases, such as sialidases, which are also associated with many viral infections, e.g., influenza. Our study thus raises
a plausible but rarely explored possibility that altered O-glycosylation
on B cells could lead to unfavorable development of lymphocytes
via the modification of their glycomes.
Our study also suggests that the absence of core 1 O-glycans on
B cells affects the development of B cell–mediated AID through
multiple mechanisms. Hyperresponsiveness of B cells is frequently
associated with B cell–mediated autoimmunity (2, 37). Mice defective
in regulators of BCR signaling, such as CD22, FcRIIb, and other
molecules, generally demonstrate hyperactivation and/or hyperproliferation of B cells, enhanced BCR signaling, and AID-like
pathology (54–60). In a related fashion, Cosmc-deficient B cells exhibit
increased basal activation, as well as responsiveness to stimuli (Fig. 3),
suggesting an inhibitory role of core 1 O-glycans on BCR signaling.
We observed more IgM+ IgD− immature B cells in the bone marrow
in BC-CosmcKO mice (23). Notably, B cell tolerance is generally
believed to be established in immature B cells. The high percentage
of Cosmc-deficient immature B cells therefore likely allows for B cells
to be checked by various tolerance mechanisms, such as BCR editing
or revision, and clonal deletion, to remove autoreactive B cells (6, 61).
However, the high amounts of autoreactive antibodies in BC-CosmcKO
mice clearly demonstrate that Cosmc deficiency leads to a breakdown of tolerance. It remains to be ascertained when and where the
tolerance mechanisms are disrupted in Cosmc-deficient B cells. In
addition, the much higher MHC II molecule levels on Cosmc-deficient
B cells suggest that they might contribute to the autoimmunity
development in additional ways, such as enhanced presentation of
self-antigen to T cells. Furthermore, as CD9 is also a marker for B1
and plasma cells (62), the up-regulated expression of CD9 on
Cosmc-deficient B cells suggests that loss of Cosmc may poise
the B cells to differentiate toward those populations.
An important unaddressed issue in B cell biology is the functional
relevance of rapid enhanced high PNA binding, which identifies
core 1 O-glycans, when a subpopulation of antigen-experienced
B cell enters GCB cell pathway. Among the surface molecular markers
that have been defined and characterized in GCB cells, the PNA
binding is especially noteworthy because it was the first marker
used to identify GCB cells four decades ago, and it is still widely
used (43, 44, 63). However, its functional relevance remains as “the
still unsolved germinal center mystery” (64). PNA preferentially
binds to nonsialylated core 1 O-glycans with a terminal galactose
residue, e.g., T antigen, as evidenced by the ability of soluble galactose
to block the binding. In line with this, we have performed glycan
microarray experiments that demonstrate that the T antigen is preferentially recognized by PNA. As expected, B cells carrying a
deletion of Cosmc exhibited substantially reduced PNA binding
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MATERIALS AND METHODS

Mice
Cosmcf/f females were generated from our previous study (19) and
bred with Mb1-Cre transgenic male mice (from M. Reth, Max
Planck Institute of Immunobiology) to generate B cell–specific Cosmc
knockout (BC-CosmcKO) mice, and male BC-CosmcKO mice were
crossed with Cosmcf/f females to generate female BC-CosmcKO
mice, which were cohoused with WT littermate controls under
specific pathogen–free conditions (21.7° ± 0.6°C, 45 ± 10% humidity,
and 12-hour light cycle of 6:00 a.m. to 6:00 p.m.) at Harvard Medical
School in accordance with approved Institutional Animal Care and
Use Committee protocols (Beth Israel Deaconess Medical Center,
Harvard Medical School). Mice are on a C57BL/6 genetic background and age- and gender-matched throughout all experiments.
Young male mice at 2 to 4 months old were used in functional study,
and for characterization of spontaneous autoimmune phenotypes,
old mice were used at 11 to 20 months old, unless stated otherwise.
All mice were euthanized by carbon dioxide overdose in a euthanasia
chamber. Mouse genotypes were determined by PCR with primers
for Mb1-Cre [hCre dir, 5′-CCCTGTGGATGCCACCTC-3′ (forward);
hCre, 5′-GTCCTGGCATCTGTCAGAG-3′ (reverse)] and Cosmcflox
[5′-GCAACA CAAAGAAACCCTGGG-3′ (forward) and 5′-TCGTCTTTGTTAGGGGCTTGC-3′ (reverse)]. In addition, phenotyping
of mice is also performed using anti-Tn and anti-CD19 antibodies
by flow cytometry, where BC-CosmcKO B cells are Tn positive and
WT B cells are Tn negative.
B cell isolation, antibodies, and flow cytometry
B cells were isolated from the spleen of WT and BC-CosmcKO mice
using a B cell isolation kit (Miltenyi Biotec, catalog no. 130-090-862) with
a purity of >95%, as determined by CD19 positivity using flow cytometry.
The antibodies were purchased from BD Biosciences, BioLegend, and
eBioscience and listed as follows: CD19, B220, CD23, CD21, CD38,
CD9, CD1d, Fas, GL7, phospho-ERK, phospho-SYK, phospho-tyrosine,
IgM, IgD, CD86, CD80, and MHC II, conjugated to fluorophores as
noted including FITC, PE, PE-Texas Red, PerCp, PE-Cy7, APC-Cy7,
Brilliant Violet, Alexa Fluor 700, or Pacific Blue. Antibodies used in
ELISA are from SouthernBiotech or Thermo Fisher Scientific. Anti-Tn
antibody conjugated to Alexa Fluor 647 was prepared in the laboratory (82) according to the manufacturer’s protocol (Thermo Fisher
Scientific, A20173). Biotinylated lectins were obtained from Vector
Laboratories and incubated at a final concentration at 2 g/ml. Single-cell
suspensions prepared from spleen were stained with indicated antibodies
at 1:100 dilution for 30 min and run on BD Biosciences FACSCalibur,
LSRII, or CytoFLEX.
For TNP-Ficoll binding assay, mice were intravenously injected
with TNP-Ficoll. Spleens were harvested after 30 min. Single-cell
suspensions were prepared for biotin–anti-TNP (BD Biosciences,
catalog no. 553978) staining, then streptavidin Alexa Fluor 488 (Life
Technologies, S32354) staining, and flow cytometric analysis.
For in vitro cell culture, splenocytes prepared from both WT and
BC-CosmcKO mice were mixed and labeled with CellTrace Violet
dye and stimulated with F(Ab′)2 fragment goat anti-mouse IgM
(10 g/ml; Jackson ImmunoResearch Laboratories, catalog no.
115-006-020) with or without the presence of anti-CD40 (1 g/ml;
eBioscience, catalog no. 16-0402-85) or ODN 1826 (1 g/ml; synthesized by IDT) in complete RPMI 1680 media [10% fetal
bovine serum, 5 mM Hepes, penicillin-streptomycin (50 U/ml),
2 mM l-glutamate, and 5 mM 2-mercaptoethanol]. After indicated
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O-glycosylated, including CD19 and Ig. It is possible that loss of
O-glycans on these molecules may alter the interactions between
BCR and endocytosis-related molecules and thereof contribute to
the altered BCR surface retention, resulting in increased surface
IgM levels, and the subsequent enhanced BCR signaling, as measured
by increased phosphorylation of ERK. However, the O-glycosylated
proteins on murine B cells are currently not defined and represent a
substantial O-glycoproteomic challenge. It is yet to be elucidated
regarding how the BCR downstream effectors are intertwined to
determine the differentiation of Cosmc-deficient B cells. Nonetheless, Cosmc deficiency seems to lower the activation threshold in
B cells, as manifested by their hyperresponsiveness to multiple
stimuli (Fig. 3). On the other hand, we found evidence of the activation of immune effectors including increased inflammatory cytokine
and potential activated complement pathways in the aged female
BC-CosmcKO mice (fig. S3). Such findings are reminiscent of those
described in AID patients and animal models (33, 35). Whether
and/or how such factors contribute to the tissue damage and, if so,
how to influence these factors to prevent injury will be intriguing to
pursue further.
Overall, our results demonstrate that BC-CosmcKO mice
spontaneously develop AID-like pathologies. Thus, Cosmc and its
cognate core 1 O-glycans on B cells act as an important checkpoint
to prevent the development of pathogenic autoreactive B cells. Our
study points to a model that Cosmc and core 1 O-glycans maintain
B cell functional homeostasis by regulating BCR internalization.
Upon loss of Cosmc, restricted internalization of the BCR and its
consequent elevation on the cell surface are associated with enhanced
BCR signaling, indicating that Cosmc negatively regulates BCR
signaling. In line with this, the Cosmc mutant animals displayed a
high production of autoreactive antibodies, as well as a range of
pathological alterations in multiple organs. Our results are also
consistent with recent studies implicating Cosmc in several autoimmune
and inflammation-associated diseases, including inflammatory bowel
diseases (24), IgAN (25), Tn syndrome (26), and Alzheimer’s disease
(27). IgAN is particularly interesting as it has been well documented
that Tn antigen expresses on the hinge region of IgA1, as well as
enhanced production of autoantibodies to the altered glycoform
and other autoantigens in patients with IgAN (71–77). In addition,
a study suggests that in some IgAN patient cohorts, there is
compromised expression of Cosmc (25). Thus, it is plausible that
Tn+ antibody-secreting B cells exist in patients with IgAN and, perhaps,
in patients with other autoimmune disorders.
While much remains to be explored in regard to the molecular
and genetic basis underlying most AIDs, our results suggest the
possibility that some type of dysglycosylation may induce B cell–
mediated autoimmunity, and the potential for Tn+ B cells in this
process should be considered. In terms of glycoprotein functions, it
is now well documented that normal O-glycans are required in
many systems for cell-cell interactions, normal glycoprotein stability,
oligomeric complex formation, and cell signaling (78–81). The
mouse model that we have presented here, in which autoimmunity
spontaneously develops, suggests a potential relevance and mechanism of Tn antigen in the induction of AIDs. In summary, our
results demonstrate an essential role of Cosmc, a regulator controlling
O-glycosylation, in maintaining B cell tolerance and prevention of
autoimmunity. These discoveries provide novel insights into the
pathogenesis of AIDs and the potential to develop new diagnostic
and therapeutic strategies for these diseases.
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periods of time, cells were pelleted and subjected to flow cytometric
analysis.
For phospho-flow cytometry, splenocytes were activated by
anti-IgM and permeabilized by dropwise adding cold methanol
while vortexing and incubated on ice for 30 min. After extensive
washing, the treated splenocytes were stained with anti–phospho-
proteins and other surface markers and subjected to flow cytometric
analysis. Data were analyzed with FlowJo software.

Histopathology
Mouse liver tissues were collected and fixed in 10% formalin, and
liver pathology was evaluated with hematoxylin and eosin (H&E)
slides (processed by Beth Israel Deaconess Medical Center histology
core facility) by two pathologists independently.
Kidney histopathology analysis
Kidneys were embedded in paraffin, sectioned onto slides, stained
with H&E, examined microscopically, and scored as follows: (i)
presence of crescents, fibrosis, or other morphological abnormalities,
including hypertrophy and membranous thickening, in glomeruli
(1 to 10%, grade 1; 10 to 25%, grade 2; 25 to 50%, grade 3; and >50%,
grade 4); (ii) tubular cell changes (1 to 10%, grade 1; 10 to 25%,
grade 2; 25 to 50%, grade 3; and >50%, grade 4); (iii) lymphocyte
infiltration (1 to 10% of renal parenchyma, grade 1; 10 to 25%,
grade 2; 25 to 50%, grade 3; and >50%, grade 4); and (iv) vasculitis
(grade 1, small but definite perivascular infiltrates; grade 2, one to
three foci of perivascular infiltrates without necrosis; grade 3, three
to five foci of perivascular infiltrate, more extensive; and grade 4,
more than five foci of perivascular infiltrates). The sum of the four
histopathology scores was calculated. The glomerular index refers
to the score of category (i) (83, 84).
Immunizations and ELISA
Eight-week-old WT and BC-CosmcKO mice were immunized intraperitoneally with 100 g of NP-KLH (Biosearch Technologies,
N-5060-5) emulsified in complete Freund’s adjuvant, 10 g of
NP-Ficoll (Biosearch Technologies, F-1300-10), or NP-LPS (Biosearch
Technologies, N-5065-1) in phosphate-buffered saline (PBS). Sera
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HEp-2 staining and confocal microscopy
Antinuclear antibodies were examined by staining of Kallestad
HEp-2 slides (Bio-Rad) with mouse serum (1:90 dilution), according
to the manufacturer’s protocol, and followed by anti-mouse IgG
conjugated to Alexa Fluor 488 and IgM conjugated to Alexa Fluor
568. Kidneys were harvested from both WT and BC-CosmcKO
mice and frozen in OCT at −80°C. The frozen tissues were sectioned
at 6 m thickness. The slides were then air-dried and fixed with cold
1:1 methanol/acetone fixative at −20°C for 10 min. After extensive
washing with PBS containing 0.05% Tween 20, slides were blocked
with 10% goat serum for 2 hours and then stained with anti-mouse
IgG conjugated to Alexa Fluor 488 (Invitrogen, A10001) and IgM
conjugated to Alexa Fluor 568 (Invitrogen, A21043) overnight. The
slides were counterstained with Hoechst 33342 (Thermo Fisher
Scientific, H3570) to visualize the nuclei, mounted with ProLong
gold reagent (Invitrogen, P36930), and analyzed with a Zeiss LSM880
confocal microscope to acquire tile scanned images, which were
then analyzed by ImageJ (Fiji).
BCR internalization
Splenocytes were preequilibrated on ice in RPMI 1640 with 0.5% BSA
and incubated with either biotinylated goat anti-mouse IgM F(ab′)
(Jackson ImmunoResearch Laboratories, catalog no. 115-067-020)
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Urinalysis
Urine was collected by holding the mouse over a collection container,
and collected urine was subjected to a Chemstrip test (Roche, reference
no. 11893467). A visual comparison of the results to the provided
color scale was performed and scored as follows: (i) for presence of
protein, below the limit of detection as 0 (negative), <30 g/ml as 1,
30 to 100 g/ml as 2, 100 to 500 g/ml as 3, and more than 500 g/ml
as 4; (ii) for presence of glucose, below the limit of detection as
0 (normal), <50 g/ml as 1, 50 to 100 g/ml as 2, 100 to 250 g/ml
as 3, and 250 to 500 g/ml as 4; (iii) for presence of nitrite, below
the limit of detection as 0 (negative) and above the limit of detection as 1 (positive); (iv) for presence of leukocytes, below the
limit of detection as 0 (negative), a “trace” finding as 1, a “+”
finding as 2, and a “++” finding as 3; (v) for presence of blood/
hemoglobin, below the limit of detection as 0 (negative), a trace
finding as 1, an about 50 erythrocytes/l finding as 2, and an about
250 erythrocytes/l finding as 3. For bicinchoninic acid protein assay
(Pierce, catalog no. 23225), urine was collected at two time points
with a 6-hour interval. All samples were analyzed in duplicate,
and the average of concentration measured from both time points
was shown.

were collected from both immunized groups at indicated time points
and stored at ≤−20°C.
For quantitative ELISA, sera from both WT and BC-CosmcKO
mice were collected, titrated, and added into 96-well plates
(Corning) in duplicate that were precoated with polyvalent goat
antibody against mouse immunoglobulins (IgM, IgG1, IgG2b, IgG2c,
IgG3, and IgA from SouthernBiotech), next followed by horseradish
peroxidase (HRP)–conjugated goat anti-mouse IgG (SouthernBiotech
and Thermo Fisher Scientific), and then developed by trimethylboron
(TMB) ELISA substrate (Abcam). Absorbance [optical density (OD)]
value was determined at 450 nm with a Multiskan Spectrum
spectrophotometer (Thermo Fisher Scientific). The concentration
of mouse immunoglobulins was calculated from a standard curve
constructed using mouse polyclonal immunoglobulins as listed:
IgM, IgG1, IgG2b, IgG2c, IgG3, and IgA (SouthernBiotech).
Indirect ELISA was used to determine NP-specific immunoglobulins. Ninety-six–well plates were precoated with nitrophenol
conjugated with bovine serum albumin (NP-BSA) or dsDNA or
ssDNA overnight. For DNA-specific IgG, plates were first coated
with protamine overnight before the coating with DNA. Plates were
then washed and blocked with PBS/BSA (2%) for 90 min at room
temperature (RT). Sera collected from immunized WT and BC-CosmcKO
mice were titrated in serial threefold dilution, added to the plates, and
incubated at RT for another 90 min. After extensively washing,
HRP-conjugated goat antibodies against mouse IgM, IgG, IgG1,
IgG2b, IgG2c, or IgG3 were added to the plates for 90 min. Plates
were washed thoroughly and developed by TMB ELISA substrate
(Abcam). Absorbance (OD) value was measured at 450 nm with a
Multiskan Spectrum spectrophotometer (Thermo Fisher Scientific).
The NP-specific antibody titer is expressed as the reciprocal of the
highest dilution as an absorbance value greater than twice that of
the blank control in the same plate. The serum levels of the cytokines TNF and IFN were measured by ELISA in accordance with
the instructions of the manufacturer (R&D Quantikine ELISA kit,
catalog nos. MTA00B and MIF00).
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or F(Ab′)2 (10 g/ml; Jackson ImmunoResearch Laboratories,
catalog no. 115-006-020). After washing, the cells were then fixed in
0.5% paraformaldehyde in PBS (denoted as T0) or allowed for internalization at 37°C for the indicated periods of time (denoted as Tn)
before immediately fixed in 0.5% paraformaldehyde in PBS. The
cells were then stained with streptavidin conjugated with Alexa
Fluor 488, and the remaining BCRs on B cell surface were analyzed
on a BD Biosciences FACSCalibur flow cytometer. The percentage
of internalized BCR was calculated according to the following
formula: 〔MFI IgM(T0) − MFI IgM (Tn)/MFI IgM(T0) × 100.
Quantitative real-time reverse transcription PCR
Total RNA was isolated from both WT and BC-CosmcKO B cells
using the RNeasy Mini Kit (QIAGEN, reference no. 74104) and
dissolved in ribonuclease-free water. One microgram of total RNA
was used to synthesize the first-strand complementary DNA using
reverse transcriptase (SuperScript III; Invitrogen, reference no.
18080-044). Quantitative PCR was carried out using the SYBR
Green PCR Master Mix (Bio-Rad) with CFX384 Touch Real-Time
PCR Detection System (Bio-Rad), with primer IGHM 5′-GCTCAGCTATGCTACGCTGT-3′ (forward) and 5′-TGTTCTGGTAGTTCCAGGTGAA-3′ (reverse). Experimental Ct values were
normalized to 36B4 or actin, and relative mRNA expression was
calculated using the ddCt method.
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Western immunoblotting
For phospho-protein Western immunoblotting, B cells purified
from both WT and BC-CosmcKO mice were treated with anti-IgM
and pelleted and lysed in radioimmunoprecipitation assay buffer
containing 150 mM NaCl, 50 mM tris-HCl (pH 7.6), 2 mM EDTA,
1% Triton X-100, and 0.1% SDS, supplemented with cOmplete
Mini EDTA-free protease inhibitor cocktail (Roche) and PhosSTOP
phosphatase inhibitors (Roche). Protein concentration was quantified
by a DC protein concentration assay kit (Pierce) before subjecting
to SDS-PAGE gel. Western blotting was performed with the following
antibodies: pERK1/2 (Cell Signaling Technology, #4695T), lamin B
(Cell Signaling Technology, #9622), and total ERK1/2 (Cell Signaling
Technology, #9194).
For C3 complement Western blot analysis, sera were prepared
from mice and stored at −20°C until use. Serum (1 l) was loaded on
SDS-PAGE and transferred to nitrocellulose membrane (Bio-Rad,
catalog no. 1704158,) using Trans-Blot Turbo Transfer System
(Bio-Rad). After blocking with 5% (w/v) nonfat milk (EMD Millipore,
catalog no. C701K28) in TBST [50 mM tris-HCl (pH 7.4), 150 mM
NaCl, and 0.05% Tween 20] for 1 hour at RT, the membranes were
incubated with anti–complement factor 3 (C3) antibody (diluted at
1:2000; rabbit recombinant monoclonal IgG, catalog no. ab200999,
Abcam) in TBST containing 1% nonfat milk for 1 hour at RT. After
washing three times with TBST for 10 min, the membranes were
incubated with HRP-labeled goat anti-rabbit IgG (KPL, catalog no.
374-1506) at 1:10,000 dilution in TBST containing 0.5% nonfat
milk for 1 hour at RT. After washing three times with TBST for 10 min,
the signals were analyzed on an Amersham Imager 600 (GE Healthcare
Life Sciences) using SuperSignal West Pico chemiluminescent
substrate (Thermo Fisher Scientific, catalog no. 34578).
Statistics
For all applicable experiments, an unpaired two-tailed Student’s
t test was performed for group comparisons using Prism software.
SUPPLEMENTARY MATERIALS

Supplementary material for this article is available at https://science.org/doi/10.1126/
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